Asthma and COPD Drugs Market Share

North American Market Forecast

The asthma and COPD drugs market in the North America region, amongst all the other regions, are projected to hold the largest share between 2025 and 2037. The growing healthcare infrastructure in the North American region is able to provide the required treatment to the patients.

In addition, the governments and private insurance companies in North America generally provide favorable reimbursement policies for drugs dispensed through pharmacies and hospitals.

APAC Market Statistics

The Asia Pacific asthma and COPD drugs market is poised to register substantial growth rate during the forecast period. The aging population in the Asia Pacific region is growing rapidly, which is expected to lead to an increase in the number of people with respiratory diseases, particularly COPD.

Several governments in the region are taking initiatives to improve healthcare access and outcomes, including for respiratory diseases. For instance, the Chinese government launched the "Healthy China 2030" initiative, which aims to reduce the burden of chronic diseases, including respiratory diseases.